Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
Joint Authors
Nazha, Bassel
Garcia, Gwenalyn
Kandov, Ruben
Odaimi, Marcel
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-04-29
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by a clonal expansion of megakaryocytes.
ET can result in both arterial and venous thrombosis.
Involvement of the coronary arteries has been reported.
Patients who harbor a CALR mutation are half as likely to suffer a thrombotic event as compared to patients with a JAK2 mutation.
We report a case of CALR-mutated ET whose initial disease manifestation was a non-ST segment elevation myocardial infarction.
American Psychological Association (APA)
Nazha, Bassel& Garcia, Gwenalyn& Kandov, Ruben& Odaimi, Marcel. 2015. Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome. Case Reports in Hematology،Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058579
Modern Language Association (MLA)
Nazha, Bassel…[et al.]. Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome. Case Reports in Hematology No. 2015 (2015), pp.1-4.
https://search.emarefa.net/detail/BIM-1058579
American Medical Association (AMA)
Nazha, Bassel& Garcia, Gwenalyn& Kandov, Ruben& Odaimi, Marcel. Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome. Case Reports in Hematology. 2015. Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058579
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058579
